From prescreening to approval: Two pivotal Demodex trials

Published: July 29, 2026

Additional Articles

Ora Unveils Breakthrough Research in Ophthalmic Clinical Trials, New Blind Canvas Project Stories at ARVO 2026
ARTICLE

Ora Unveils Breakthrough Research in Ophthalmic Clinical Trials, New Blind Canvas Project Stories at ARVO 2026

May 12, 2026
Setting Eligibility Criteria
ARTICLE

Setting Eligibility Criteria

Learn more about how inclusion and exclusion criteria can set the stage for study approval.
Apr 18, 2024
How Do You Qualify The Qualitative?
ARTICLE

How Do You Qualify The Qualitative?

When it comes to scales, we should be asking the question: are we all on the same page? Is your 2+ redness the same as mine?
Apr 18, 2024
The Drug Development Path
ARTICLE

The Drug Development Path

Gain insight on the different steps and phases of the clinical development journey.
Apr 18, 2024

For over 50 years, Ora has been on the leading edge of ophthalmic product development.

Let’s work together to move your program forward.

Get In Touch